journal article·2026-05

Bifunctional Peptide Amphiphile Hydrogel Orchestrates Concerted Antioxidant and Anti‐Inflammatory Actions to Counter Myocardial Ischemia/Reperfusion Injury

Yuanyuan Wu, Siman Luo, Guanghui Xu, Xu Liao, Huiming Chen, Yajie Wu, Zhiye Wu, Xi Xie, Zhimou Yang, Jie Zhan, Yanbin Cai

Advanced Healthcare Materials· Volume 15· Issue 20
Publisher page

Abstract

ABSTRACT Myocardial ischaemia/reperfusion injury presents significant clinical challenges driven by a self‐perpetuating cycle of oxidative stress and inflammation. Current therapeutic strategies fail to simultaneously address these interconnected pathological events. Here, we present T&A‐Gel, a supramolecular peptide amphiphile hydrogel integrating α‐tocopherol and Angiotensin‐(1‐7) (Ang‐(1‐7)) through covalent conjugation to enable localized co‐delivery and synergistically disrupt this oxidative‐inflammatory feed‐forward circuit. Upon hierarchical self‐assembly into filamentous nanofibres, T&A‐Gel forms a sustained‐release depot that exposes Ang‐(1‐7) moieties while sequestering hydrophobic α‐tocopherol. This design enables α‐tocopherol to scavenge excess reactive oxygen species, ameliorating oxidative mitochondrial dysfunction and reducing cardiomyocyte apoptosis, while exposed Ang‐(1‐7) acts as a selective Mas receptor (MasR) agonist, activating the protective MasR/PI3K/Akt signaling axis. This dual‐action mechanism suppresses NF‐κB nuclear translocation and inhibits pro‐inflammatory cytokine cascades. In vitro, T&A‐Gel significantly enhanced hypoxia/reoxygenation‐injured cardiomyocyte viability. In vivo, T&A‐Gel demonstrated prolonged retention with substantial reduction in infarct size and cardiac necrosis biomarkers. Quantitative analysis confirmed substantial attenuation of interstitial fibrosis and cardiomyocyte hypertrophy, translating into restored ejection fraction and reduced ventricular dilation with excellent biocompatibility. These findings establish injectable supramolecular hydrogels as a powerful strategy for disrupting the interconnected injury cascade via mechanistically complementary payloads, offering a paradigm for precision cardioprotection.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Tissue Engineering and Regenerative Medicine · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease Department of Cardiology and Laboratory of Heart Center Zhujiang Hospital Southern Medical University Guangzhou P. R. China

School of Pharmaceutical Sciences Southern Medical University Guangzhou P. R. China

State Key Laboratory of Optoelectronic Materials and Technologies Guangdong Province Key Laboratory of Display Material and Technology School of Electronics and Information Technology Sun Yat‐sen University Guangzhou P. R. China

Nankai International Advanced Research Institute Nankai University (Shenzhen Futian) Shenzhen Guangdong P. R. China

Department of Laboratory Medicine Guangdong Provincial Key Laboratory of Precision Medical Diagnostics Nanfang Hospital Southern Medical University Guangzhou P. R. China

Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors Guangdong Provincial Key Laboratory of Single‐cell and Extracellular Vesicles Nanfang Hospital Southern Medical University Guangzhou P. R. China

Funding

National Natural Science Foundation of China · Basic and Applied Basic Research Foundation of Guangdong Province

References (45)

Show source-provided references
1. 10.1038/s41569-023-00884-010.1038/s41569-023-00884-0 ↗
2. 10.1016/S0140-6736(16)30677-810.1016/S0140-6736(16)30677-8 ↗
3. 10.1021/acsnano.4c1444510.1021/acsnano.4c14445 ↗
4. 10.1038/s41392-025-02253-410.1038/s41392-025-02253-4 ↗
5. 10.1038/s41556-024-01429-410.1038/s41556-024-01429-4 ↗
6. 10.1002/adhm.20240431910.1002/adhm.202404319 ↗
7. Mitochondria Regulate Intracellular Coenzyme Q Transport and Ferroptotic Resistance via STARD7
8. 10.1038/s41467-023-40081-810.1038/s41467-023-40081-8 ↗
9. 10.1021/acsnano.4c0050910.1021/acsnano.4c00509 ↗
10. 10.1016/j.redox.2019.10129210.1016/j.redox.2019.101292 ↗
11. 10.1002/advs.20230536310.1002/advs.202305363 ↗
12. 10.1038/s41392-023-01688-x10.1038/s41392-023-01688-x ↗
13. 10.1161/CIRCRESAHA.116.30770810.1161/CIRCRESAHA.116.307708 ↗
14. 10.7150/thno.5364410.7150/thno.53644 ↗
15. Cardioprotective Angiotensin‐(1‐7) Peptide Acts as a Natural‐Biased Ligand at the Angiotensin II Type 1 Receptor
16. 10.1002/mco2.70310.1002/mco2.703 ↗
17. 10.1161/HYPERTENSIONAHA.124.2269310.1161/HYPERTENSIONAHA.124.22693 ↗
18. 10.1093/eurheartj/ehad34710.1093/eurheartj/ehad347 ↗
19. 10.1016/j.arr.2022.10161210.1016/j.arr.2022.101612 ↗
20. 10.1021/acs.jafc.1c0716110.1021/acs.jafc.1c07161 ↗
21. 10.1007/s12035-018-0966-310.1007/s12035-018-0966-3 ↗
22. 10.1016/j.carbpol.2025.12414910.1016/j.carbpol.2025.124149 ↗
23. 10.1161/HYPERTENSIONAHA.118.1201210.1161/HYPERTENSIONAHA.118.12012 ↗
24. 10.1073/pnas.171183711510.1073/pnas.1711837115 ↗
25. 10.1021/ja503882s10.1021/ja503882s ↗
26. 10.1021/acs.accounts.7b0029710.1021/acs.accounts.7b00297 ↗
27. 10.7150/thno.5364410.7150/thno.53644 ↗
28. 10.1186/s12951-022-01390-010.1186/s12951-022-01390-0 ↗
29. 10.1021/jacs.2c0575910.1021/jacs.2c05759 ↗
30. 10.1002/adma.20250332410.1002/adma.202503324 ↗
31. 10.1002/smll.20230739010.1002/smll.202307390 ↗
32. 10.1126/sciadv.adv899910.1126/sciadv.adv8999 ↗
33. 10.1021/acsnano.4c0203010.1021/acsnano.4c02030 ↗
34. Peptide Hydrogel‐Drug Conjugates for Tailored Disease Treatment
35. 10.1038/s41565-025-01981-610.1038/s41565-025-01981-6 ↗
36. 10.1021/acsnano.5c0246210.1021/acsnano.5c02462 ↗
37. 10.1016/j.biomaterials.2023.12245310.1016/j.biomaterials.2023.122453 ↗
38. 10.1016/j.biomaterials.2022.12184910.1016/j.biomaterials.2022.121849 ↗
39. 10.1002/INMD.2022000510.1002/INMD.20220005 ↗
40. 10.1002/adhm.20230161510.1002/adhm.202301615 ↗
41. 10.1038/s41401-021-00820-310.1038/s41401-021-00820-3 ↗
42. 10.1038/s41467-023-36629-310.1038/s41467-023-36629-3 ↗
43. 10.1016/j.actbio.2022.06.03910.1016/j.actbio.2022.06.039 ↗
44. 10.1002/INMD.2023001810.1002/INMD.20230018 ↗
45. 10.1016/j.jconrel.2024.12.04210.1016/j.jconrel.2024.12.042 ↗